Ladenburg Thalmann Downgrades Novavax (NVAX) to Neutral
Tweet
Share
E-mailGet Alerts NVAX Hot Sheet
Price: $8.79 +10.84%
Rating Summary:
10 Buy, 3 Hold, 5 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 24
Rating Summary:
10 Buy, 3 Hold, 5 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 24
Join SI Premium – FREE
Ladenburg Thalmann downgraded Novavax (NASDAQ: NVAX) from Buy to Neutral and removed its price target (prior $14.15).
For an analyst ratings summary and ratings history on Novavax click here. For more ratings news on Novavax click here.
Shares of Novavax closed at $8.34 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Novavax (NVAX) 11K contracts of August 28 weekly 9 calls trade, share price up 8.8%
- UBS Downgrades Core Natural Resources (CNR) to Neutral
- Deutsche Bank Downgrades Shurgard Self Storage SA (SHUR:BB) to Hold
Create E-mail Alert Related Categories
DowngradesRelated Entities
Ladenburg Thalmann Financial ServicesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
